Table 1

Pharmacokinetic summary for patients treated with KW-2449

Dose levelDaily dose, mgNo. of patientsKW-2449, 2 hours, nMM1, 2 hours, nMKW-2449, 12 hours, nMM1, 12 hours, nM
25 20.5 165.7 1.2 76.1 
50 24.5 204.4 2.5 68.6 
100 74.1 693 7.1 241.4 
200 111.3 593.2 12.6 290.3 
300 264 1865 17.6 413.8 
400 387.2 2130 21.1 491.7 
500 515.0 2867 102.5 420.3 
Dose levelDaily dose, mgNo. of patientsKW-2449, 2 hours, nMM1, 2 hours, nMKW-2449, 12 hours, nMM1, 12 hours, nM
25 20.5 165.7 1.2 76.1 
50 24.5 204.4 2.5 68.6 
100 74.1 693 7.1 241.4 
200 111.3 593.2 12.6 290.3 
300 264 1865 17.6 413.8 
400 387.2 2130 21.1 491.7 
500 515.0 2867 102.5 420.3 

Mean levels of KW-2449 and the metabolite, M1, are shown at 2 and 12 hours after dosing on day 1. The daily dose shown was administered in 2 divided doses, 12 hours apart (ie, 25 mg = 12.5 mg twice daily).

Close Modal

or Create an Account

Close Modal
Close Modal